Clinical Trial Update: Hernia Abd Wall Recons - BDE vs Exparel [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update comparing BDE and Exparel for abdominal wall hernia patients, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Wall Hernia
• Hernia Abdominal

Drugs mentioned

• BDE
• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Baylor Research Institute | Conditions: BDE for Hernia Patients, Exparel for Hernia Patients | Phase 2 | Status: ENROLLING_BY_INVITATION